Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04970641 · ClinicalTrials.gov registry record · NA
Three Good Things (3GT) - Intervention for Transitional Care Patients
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT04970641: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT04970641 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04970641, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Researchers are doing this research study to learn how the Three Good Things (3GT) Positive Psychology journaling activity affects symptoms of stress, depression, resilience, and happiness.
Primary Outcome
Change in subject perceived stress measured using the self-reported perceived stress scale (PSS). A 10-item questionnaire assessing individuals' appraisal of stress using a scale of 0=never, 4=very often.
Interventions
- BEHAVIORAL Three Good Things (3GT) Positive Psychology journaling activity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2021-09-30 |
| Est. Completion | 2023-12-01 |
| Phase | NA |
Why NCT04970641 stopped before completion
NCT04970641 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Three Good Things (3GT) Positive Psychology journaling activity is the first listed.
NCT04970641 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04970641 about?
NCT04970641 is a clinical study titled "Three Good Things (3GT) - Intervention for Transitional Care Patients". Researchers are doing this research study to learn how the Three Good Things (3GT) Positive Psychology journaling activity affects symptoms of stress, depression, resilience, and happiness.
What is the current status of trial NCT04970641?
This trial is currently terminated. It is a NA study. The enrollment target is 25 participants. The study started on 2021-09-30. Estimated completion is 2023-12-01.
What interventions are being tested in trial NCT04970641?
The interventions under investigation include: Three Good Things (3GT) Positive Psychology journaling activity (BEHAVIORAL).
Who is sponsoring clinical trial NCT04970641?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04970641's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI